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ABSTRAK
Hipertensi portal non-sirosis merupakan salah satu penyebab dari hematemesis dan melena  yang cukup 
jarang terdiagnosa. Seperti pada pasien sirosis hepatis, pada pasien dengan hipertensi portal non-sirosis, 
hematemesis dan melena terjadi karena ruptur varises esofagus. Namun berbeda dengan sirosis hepatis, pada 
pasien hipertensi portal non-sirosis tidak ada tanda-tanda gagal hati, yang merupakan ciri khas dari sirosis 
hepatis. Telah dilaporkan pasien pria dengan hipertensi portal non-sirosis yang mengalami hematemesis akibat 
ruptur varises esofagus
Kata kunci: hipertensi portal non-sirosis, hematemesis, ruptur varises esofagus.
ABSTRACT
Non-Cirrhotic Portal Hypertension (NCPH) is a rare cause of hematemesis and melena. Like in cirrhotic 
patient, hematemesis in NCPH patient was caused by rupture of esophageal varices. But unlike in cirrhotic 
patient, in NCPH there are no sign of liver failure, because liver physiology is still normal. We reported case of 
male patient with NCPH that had hematemesis because of rupture of esophageal varices.
Keywords: non-cirrhotic portal hypertension, hematemesis, rupture variceal esophagus.
INTRODUCTION
Non Cirrhotic Portal Hypertension is a 
disease characterized by periportal fibrosis and 
involvement of small and medium branches of 
the portal vein, resulting to intrahepatic portal 
hypertension in the absence of cirrhosis or other 
cause of liver disease.1
NCPH is more prevalent in Asia than in 
western country. NCPH related with hygiene 
and socioeconomy status, worsen status increase 
prevalence of NCPH. In Asia, male and younger 
patient were more frequent diagnose had NCPH 
than in western country.1-6
Symptoms of NCPH is caused by increase 
of portal vein pressure. Splenomegaly, 
thrombocytopenia, variceal esophagus are some 
sign of portal hypertension.
Treatment of NCPH is non specific, usually 
to prevent further complication. The most 
prevalent complication of NCPH is rupture of 
esophageal varices.
CASE ILLUSTRATION
A 18-year-young male patient came to Saiful 
Anwar Hospital with bloody vomiting since 6 
days ago reffered from previous small hospital 
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and got treatment from it but no improvement. 
He complained bloody vomiting 3-4 times a 
day with each vomit approximately 250 cc and 
blacktarry stool approximately 100 cc a day. 
He felt weak and epigastric pain before vomit 
and complained his stomach become bigger 
than before. Last year, he also hospitalized with 
same complaint and already consumed 10 mg 
propranolol twice a day, 100 mg spironolactone 
once daily and 30 cc lactulose syrup three times 
a day if difficult to passing stool. His grandfather 
already passed away with liver disease but the 
family could not mention the name of the disease. 
History of consumed traditional potion, pain 
killer drugs, and alcohol were denied. Patient 
had just graduated from senior high school 1 
year ago and because his disease he can not do 
heavy work.
Physical examination revealed blood 
pressure  120/60 mmHg, pulse rate 100x/minute, 
respiratory rate 18x/minute, axillary temperature 
36.7°C, BMI 21.4 kg/m², in head and neck 
examination we found anemic conjunctiva, and 
there was no alopecia, in chest examination we 
did not find gynecomastia, spider naevus, heart 
and lung were normal. Liver span was 10 cm 
with flat surface, sharp edge, dense, and no pain 
in pressure, shifting dullness was positive, and 
traube space dullness, spleen Schuffner I. In his 
extremities we did not find edema and there was 
no palmar erythema.
Laboratory tests showed hemoglobin levels of 
5.6 g/dl, leucocyte count 8.300/µL, thrombocyte 
count 71,000/µL. His serum albumin levels was 
2.26 g/dL with globulin levels of 1.51 g/dL, his 
liver function, renal function, serum electrolyte, 
bilirubin, hepatitis B and C serology marker, 
ANA test, and hemostatic function were within 
normal range. Chest X-ray within normal range, 
Abdominal USG revealed splenomegaly and 
ascites, Doppler USG revealed PSV 12.1 cm/s, 
portal hypertension but no thrombus in portal 
vein 
Endoscopy showed esophageal varices 
grade II-III and liver biopsy showed metavir F1 
(portal fibrosis without septa) and the ascites 
fluid analysis reveals transudate with Rivalta 
test negative.
Patient was diagnosed with Idiopathic Non-
Cirrhotic Portal Hypertension. He was done 
gastric lavage with normal saline every 8 hours 
until the bleeding stop, 20 drops/minute of IVFD 
of normal saline (0.9% Nacl solution), PRC 
transfussion 2 packs/day until Hb> 8g/dL, 50 µg 
octreotide intravenous continued with 250 µg/
hour until 72 hours bleeding stop, 1 gram daily 
ceftriaxone, 60 mg lansoprazole continued with 
6 mg/hour, 10 mg metoclopramide three times 
daily, and 30 cc lactulose syrup three times daily 
via nasogatric tube. He suffered from recurrent 
bleeding until day 10 and finally we decided to 
do emergency endoscopy and band ligation of 
esophageal varices and the bleeding was stop, 3 
days after bleeding stop and the vital sign were 
stable, he was go home and prescribed with 
10 mg propranolol three times daily, 100 mg 
Figure 1. Doppler USG
Figure 2. Endoscopy show esophageal 
varices grade III-IV Figure 3. Endoscopy post band ligation
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spironolactone once daily, and 30 cc lactulose 
syrup three times a day. We educate the patient 
about the compliance to prevent the bleeding 
occurred.
DISCUSSION
The Asian Pacific Association for the Study 
of the Liver (APASL) defines INCPH as a 
disease of uncertain etiology characterized by a 
periportal fibrosis and involvement of small and 
medium branches of the portal vein, resulting in 
the development of portal hypertension.1
Diagnosis of INCPH is rendered in patients 
that have portal hypertension, after excluding 
portal vein thrombosis, Budd-Chiari syndrome, 
exposure of toxin and medication, cirrhosis 
hepatis, chronic viral hepatitis, and other liver 
disease.
INCPH is commonly reported in developing 
countries and in lower socioeconomic groups. 
INCPH is a common cause of portal vein 
hypertension in Japan and India, about 30-40%, 
but only 3-4% porta hypertension were caused 
by INCPH in western hemisphere. However the 
true prevalence of INCPH might be higher, since 
patient misdiagnosed as cirrhosis patient. In India 
and western m INCPH is more frequent in male, 
while in Japan, female is more frequent. In India 
age of onset INCPH is younger (25-25 year old) 
compare in Japan (43-56 year old) and western 
(median 40 years old).1,3-5
No definitive etiology of INCPH. Roughly, 
the potential mechanisms involved in INCPH 
pathogenesis can be classified in five main 
categories: immunological disorders, chronic 
infections, exposure to medications or toxins, 
genetic disorders and prothrombotic conditions.5
Clinical sign of INCPH is related to 
hypertension porta without sign of liver failure. 
Variceal bleeding is the most common sign, 
but unlike in cirrhotic patient, prognose of 
variceal bleeding in INCPH is usally good. 
Ascites is reported in up to 50% of cases, and it 
usually develops in the context of precipitating 
factors such as variceal bleeding or infections. 
Generally, it is easily controlled with low dose 
of diuretics and resolution of the trigger. Hepatic 
encephalopathy is a rare complication and it is 
also related to precipitating factor. Splenomegaly 
also not uncommon in INCPH.3
In our patient, he had hematemesis that 
related to variceal bleeding (diagnosed with 
endoscopy) and also splenomegaly and ascites. 
He also did not show any sign of liver failure, 
eg; gynaecomastia, palmar erythema and also no 
edema in his lower extremity.
Diagnosis of INCPH is diagnosis of 
exclusion, based of following criteria, 1) presence 
of unequivocal signs of portal hypertension 
(e.g., gastroesophageal varices, ascites, and/or 
splenomegaly); 2) absence of cirrhosis, advanced 
fibrosis or other causes of chronic liver diseases 
that can cause PH by appropriate serological, 
biochemical tests and liver biopsy and; 3) 
absence of thrombosis of the hepatic veins or 
of the portal vein at imaging studies performed 
at diagnosis.
Liver function test are normal, jaundice 
is rarely seen. Anemia, leukopenia and 
thrombocytopenia are common, because of 
hypersplenism.
In our patient, liver function test was 
normal, ratio albumin and globuline normal, 
there is no hyperbilirubrinemia and also normal 
coagulation test. He had anemia, maybe related to 
hematemesis but also because of hypersplenism. 
He also had thrombocytopenia because of 
hypersplenism. Marker for chronic viral hepatitis 
and also ANA test (to exclude autoimmune 
Table 1. Diagnostic criteria of idiopathic non-cirrhotic 
portal hypertension2
Clinical sign of portal 
hypertension
 - Splenomegaly
 - Esophageal varices
 - Ascites
 - Portovenous collateral
Exclusion of cirrhosis 
on,liver biopsy
Must had significant 
fibrosis
Exclusion of chronic liver 
disease causing cirrhosis/
Non cirrhotic portal 
hypertension
 - Chronic viral hepatitis 
B and C
 - NASH(nonalcoholic 
Steatohepatitis)
 - Autoimmune hepatitis
 - Hereditary 
hemochromatosis
 - Wilson’s disease
 - Primary biliary cirrhosis
Exclusion of condition 
causing non cirrhotic portal 
hypertension
 - Congenital liver fibrosis
 - Sarcoidosis
 - Schistosomiasis
Patent portal and hepatic 
veins
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hepatitis) were normal. These test result showed 
that patient did not have any sign of liver failure.
Ultrasound is the first imaging modality 
study, in NCPH abdominal USG show normal 
liver, but sometime show chronic liver disease 
sign (nodularity), despite the lack of histological 
cirrhosis. Splenomegaly and echogenic thick 
walled portal vein. Contrast enhanced CT scan 
or MRI also can differentiated between cirrhosis 
and INCPH. Doppler USG also show  increase in 
hepatic vein pressure gradien, normally 5 mmHg, 
but in NCPH hepatic vein pressure gradien more 
than 10 mmHG. From endoscopy we could find 
esophageal varices.
Our patient’s imaging study show chronic 
liver disease with splenomegaly and ascites, 
from abdominal USG. It is still possible INCPH 
patients from USG had chronic liver disease 
and unrelated to histopathology result. CT scan 
angiography show hepar cyst segmen 8 and 
splenomegaly. His endoscopy show esophageal 
varices grade III-IV.
Liver biopsy is also an important diagnostic 
tool, to help differentiate between significant 
fibrosis (cirrhosis) and INCPH. In INCPH, we 
can find obliteration of small portal vein, and 
also minimal fibrosis. Our patient histopathology 
study show metavir F1 (that means fibrosis 
periportal without septa).
Management of INCPH is non specific, 
usually focus on management of its complication. 
The most common complication of INCPH 
is hematemesis cause by variceal bleeding. 
Principally management of hematemesis melena 
in INCPH and in cirrhotic hepatis is same. 
Vasoactive agents like octreotide or somatostatin 
used to stop bleeding, proton pump inhibitor 
(PPI) and ligation of variceal and beta blocker for 
prevention of rebleeding. In our cases, our patient 
bleeding could not control only by vasoactive 
agent (octreotide) and PPI (lanzoprazole), and 
finally in his 10th day treatment, we decided to 
do endoscopy emergency to stop the bleeding 
followed by ligation of variceal esophagus. After 
endoscopy, patient’s bleeding is controlled, and 
after 13th day treatment he could continue his 
medication as outpatient clinic.
CONCLUSION
INCPH is not uncommon in Asia, sometimes 
we misdiagnosed it as cirrhotic patient, although 
initial treatment for complication is quite similar 
with cirrhosis patient, INCPH patient’s had a better 
prognoses than in cirrhosis patient. Diagnosis of 
INCPH, is a diagnosis of exclusion,we must 
exclude other causes of hypertension portal 
before we diagnose INCPH. Laboratory finding, 
imaging study and also histopathology study help 
us to diagnose INCPH.
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